Pyxant Labs Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pyxant Labs Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10913
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that offers laboratory services. The laboratory’s services include picogram-level bioanalytical method development and validation, analytical and bioanalytical support for ADME studies, and analytical and bioanalytical support for pharmacokinetic or pharmacodynamic studies. It also provides metabolism and toxicology bioanalytical support, pharmaceutical and bioequivalence support, medication management, GLP bioanalysis, and others. The laboratory offers bioanalytical services for the assay of RNA therapeutics and hybridization assays platforms, and regulatory development studies for serum, plasma and various tissues. Pyxant is headquartered in Colorado Springs, Colorado, the US.

Pyxant Labs Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pyxant Labs Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Pyxant Labs Raises Additional USD0.1 Million Financing 9
Pyxant Labs Raises USD0.4 Million in Venture Financing 10
Pyxant Labs Raises USD0.7 Million in Financing Round 11
Pyxant Labs Inc – Key Competitors 12
Pyxant Labs Inc – Key Employees 13
Pyxant Labs Inc – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pyxant Labs Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Pyxant Labs Raises Additional USD0.1 Million Financing 9
Pyxant Labs Raises USD0.4 Million in Venture Financing 10
Pyxant Labs Raises USD0.7 Million in Financing Round 11
Pyxant Labs Inc, Key Competitors 12
Pyxant Labs Inc, Key Employees 13

List of Figures
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pyxant Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Pyxant Labs Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OncoMed Pharmaceuticals, Inc. (OMED):企業概要、財務及び戦略的SWOT分析
    Summary OncoMed Pharmaceuticals, Inc. (OncoMed) is a biotechnology company. The company discovers and develops monoclonal antibody therapeutics. Its product pipeline includes demcizumab, OMP-59R5, vantictumab, OMP-52M51, OMP-54F28, OMP-305B83, and anti-RSPO-LGR, among others. The company also develo …
  • Huegli Holding AG:企業の戦略・SWOT・財務分析
    SummaryHuegli Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Adana Cimento Sanayii T.A.S.:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Adana Cimento Sanayii T.A.S." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric stric …
  • Airband Communications, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Airband Communications, Inc. Me …
  • MyoKardia Inc (MYOK):企業のM&A・提携動向(医療分野)
    Summary MyoKardia Inc (MyoKardia) is a clinical stage biopharmaceutical company which discovers, develops and commercializes therapies for rare cardiovascular diseases. It primarily focuses on the treatment of heritable cardiomyopathies. The company’s pipeline portfolio includes MYK-461 is an orally …
  • Midshire Catering Services Limited:企業の戦略・SWOT・財務情報
    Midshire Catering Services Limited - Strategy, SWOT and Corporate Finance Report Summary Midshire Catering Services Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Business Development Bank of Canada:企業の戦略・SWOT・財務分析
    SummaryBusiness Development Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • Hikari Tsushin, Inc. (9435):企業概要、財務及び戦略的SWOT分析
    Summary HIKARI TSUSHIN, INC. (HIKARI) is engaged in providing diversified services such as Corporate Business, SHOP Business, Insurance Business and Venture Fund Business. The Corporate Business segment primarily involves in the sale of office automation equipment, sale of fixed and broadband teleco …
  • National Health Research Institutes:製薬・医療:M&Aディール及び事業提携情報
    Summary National Health Research Institutes (NHRI) is a non-profit foundation that performs medical research programs. The foundation investigates various aspects of basic biomedical sciences and diseases including aging, cancer, infectious diseases, mental disorders and occupational diseases. It co …
  • Mastek Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mastek Limited Mergers and Acqu …
  • EDF Energies Nouvelles SA(エネルギー分野):企業M&A動向
    Summary EDF Energies Nouvelles SA (EDF Energies), a subsidiary of Electricite de France S.A., develops, constructs, operates, and maintains green electricity power plants in Europe and North America. The company produces electricity from various renewable energy sources such as wind, solar, hydro an …
  • The Miyazaki Taiyo Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Miyazaki Taiyo Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Miyazaki Taiyo Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • E.I.D. Parry (India) Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' E.I.D. Parry (India) Limited Me …
  • Total Gabon SA (EC):企業のM&A・提携動向(石油・ガス分野)
    Summary Total Gabon SA (Total Gabon), formerly Elf Gabon S.A, a subsidiary of Total S.A. is an oil and gas company that offers oil exploration services. The company explores and extracts hydrocarbon resources and extending and development the life of its mature fields. Its activities include mining …
  • Dr. August Oetker Nahrungsmittel KG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dr. August Oetker Nahrungsmitte …
  • Associated Electric Cooperative Inc.:発電所・企業SWOT分析
    Associated Electric Cooperative Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Galilee Energy Ltd (GLL):石油・ガス:M&Aディール及び事業提携情報
    Summary Galilee Energy Ltd (Galilee) is a mining and minerals exploration and development company that offers exploration and development services. The company acquires, explores, produces, and develops coal seam gas in the Galilee Basin near Longreach in Queensland. It offers projects such as ATP79 …
  • CSR plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CSR plc Mergers and Acquisition …
  • Nevro Corp (NVRO):企業財務及び戦略的SWOT分析
    Summary Nevro Corp (Nevro) is a healthcare service provider that offers pain relief therapies for low back pain and other types of chronic pain. The company provides services such as SCS therapy and clinical trials. Its SCS therapy is a low-frequency spinal cord stimulation therapy. It uses implanta …
  • W. R. Berkley Corporation:企業の戦略・SWOT・財務分析
    SummaryW. R. Berkley Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆